Brad's CLL Series

“It Was the High and the Low.”

Brad Adams was diagnosed with chronic lymphocytic leukemia (CLL) in 2010. For four years, he was on watch and wait at MD Anderson Cancer Center until 2014 when it was time for him to undergo his first round of treatment.

In this installment, the first of a three-part series, Brad describes his first round of treatment of fludarabine (Fludara), cyclophosphamide (Cytoxan or Neosar), and rituximab (Rituxan), a combination known as FCR.

Support for this series has been provided by BeiGene. Patient Power maintains complete editorial control and is solely responsible for program content.

© 2024 HealthCentral LLC. All rights reserved.